Heart Disease Trial, Recruiting NCT04521699 Sponsor: Mayo Clinic Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT04521699
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who are able to use the CamliGo device for 12 weeks
  • People who are willing to complete study questionnaires, blood tests, and EndoPat testing (a test of blood vessel function) at the start and end of the study
  • People who have recently had a heart attack and are scheduled to attend a Cardiac Rehabilitation program
  • People who have had a heart procedure in a cardiac catheterisation laboratory within the last month, including procedures such as coronary stenting, balloon angioplasty, transcatheter aortic valve replacement, mitral valve procedures, closure of a hole in the heart (patent foramen ovale), alcohol septal ablation, or paravalvular leak closure
  • People attending a Chest Pain Clinic for atypical (unusual or hard to explain) chest pain

Who may not be able to join:

  • People with cognitive impairment (conditions that affect memory, thinking, or understanding)
  • People with a diagnosis of Bipolar disorder, psychosis, or delusional disorder
  • People with a history of substance abuse or dependence
  • People with a history of suicidal thoughts or behaviour
  • People with unstable heart or lung disease
  • People with a history of seizures
  • People with a latex allergy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Valentina Nardi, M.D., Mayo Clinic

Phone: 507-255-0630

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
13 January 2022
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Peripheral endothelial function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov